Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Oelke

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Translational Medicine|October 14, 2011
Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequenciesSabine Tischer, Megan Basila, Britta Maecker-Kolhoff, et al.
Anticancer Research|August 8, 2009
Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunityRobert L Giuntoli, Tonya J Webb, Alessia Zoso, et al.
Digestive Diseases and Sciences|May 22, 2003
Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosisKai-Wolfgang Roesler, Wolfgang Schmider, Manfred Kist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2015
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsHeiko Bruns, Catherine Bessell, Juan Carlos Varela, et al.
Frontiers in Immunology|January 9, 2019
Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond ImmunosuppressionSzilvia Bak, Sabine Tischer, Anna Dragon, et al.
Transfusion|October 13, 2017
Cord blood-derived T cells allow the generation of a more naïve tumor-reactive cytotoxic T-cell phenotypeJulian Kwoczek, Sebastian B Riese, Sabine Tischer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer CellsIrina V Tiper, Sarah M Temkin, Sarah Spiegel, et al.
Cancer Research|November 26, 2009
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancerStefano Ugel, Alessia Zoso, Carmela De Santo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2020
Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting CellsJunya Ichikawa, Tatsuya Yoshida, Ariel Isser, et al.
Cancer Research|June 1, 2012
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancerTonya J Webb, Xiangming Li, Robert L Giuntoli, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|October 14, 2011
Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequenciesSabine Tischer, Megan Basila, Britta Maecker-Kolhoff, et al.
Anticancer Research|August 8, 2009
Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunityRobert L Giuntoli, Tonya J Webb, Alessia Zoso, et al.
Digestive Diseases and Sciences|May 22, 2003
Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosisKai-Wolfgang Roesler, Wolfgang Schmider, Manfred Kist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2015
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsHeiko Bruns, Catherine Bessell, Juan Carlos Varela, et al.
Frontiers in Immunology|January 9, 2019
Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond ImmunosuppressionSzilvia Bak, Sabine Tischer, Anna Dragon, et al.
Transfusion|October 13, 2017
Cord blood-derived T cells allow the generation of a more naïve tumor-reactive cytotoxic T-cell phenotypeJulian Kwoczek, Sebastian B Riese, Sabine Tischer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer CellsIrina V Tiper, Sarah M Temkin, Sarah Spiegel, et al.
Cancer Research|November 26, 2009
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancerStefano Ugel, Alessia Zoso, Carmela De Santo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2020
Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting CellsJunya Ichikawa, Tatsuya Yoshida, Ariel Isser, et al.
Cancer Research|June 1, 2012
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancerTonya J Webb, Xiangming Li, Robert L Giuntoli, et al.
Pageof 5